ResearcherUniversity of California, Los AngelesNo recent work listed
Kristina Y. Aguilera
Matched on ORCID iD 0000-0002-0877-9798; OpenAlex author ID A5082422627. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper
Papers 4
- Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand-Addicted Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-21-0623↗
- WNT Ligand Dependencies in Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.671022↗
- Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1535-7163.mct-16-0834↗
- Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-13-2800↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David W. Dawson · 2 shared papers, 2021–2022 · strength 0.43
- Timothy R. Donahue · 1 shared paper, 2022 · strength 0.15
- Caius Gabriel Radu · 1 shared paper, 2022 · strength 0.15
- Rolf A. Brekken · 2 shared papers, 2014–2017 · strength 0.10
- Paper Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1535-7163.mct-16-0834↗
- Paper Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarci… DOI 10.1158/0008-5472.can-13-2800↗
- Moriah M. Hagopian · 1 shared paper, 2017 · strength 0.06
- Wenting Du · 1 shared paper, 2017 · strength 0.06
- Huamin Wang · 1 shared paper, 2017 · strength 0.06
- Huocong Huang · 1 shared paper, 2017 · strength 0.06
- Jason B. Fleming · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.